Epocrates
For u.S.-based healthcare professionals including physicians, nurse practitioners, and pharmacists requiring rapid drug information at the point of care.
Snapshot
Who is Epocrates?
Providing U.S. healthcare professionals with point-of-care clinical decision support tools to improve prescribing safety and efficiency.
Target audience
Portfolio
Free 1Last updated
epocrates: Drug Info & Pill ID
v26.4.0
4mo ago
Publisher DNA
What defines Epocrates?
Publisher DNA
Primary focus
Clinical decision support and medical reference tools
Scale
indie
Target audience
U.S.-based healthcare professionals including physicians, nurse practitioners, and pharmacists requiring rapid drug information at the point of care.
Signature Patterns
- •Focus on high-utility clinical tools including drug interaction checkers and pill identification.
- •Freemium monetization model utilizing a core free tier and a premium 'Epocrates+' subscription.
- •Strict targeting of U.S.-based professional medical practitioners and students.
- •High-frequency update cycle to maintain clinical data accuracy and address technical performance.
Portfolio momentum
Maintains an intense development cadence with 11 updates in the last 6 months for its single flagship medical reference title.
Portfolio
What does Epocrates ship?
Apps
1 app analysed
Unique 30-drug interaction checker and visual Pill ID
- Clinical Utility
- Aggressive Monetization
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
1
Negative apps
24/100
Avg sentiment score
Rivals
Who does Epocrates compete with?
The rivals identified
Nemeses(1)
Sanford Guide Antimicrobial competes for the same clinical audience by providing specialized infectious disease treatment data, which overlaps with the core drug reference utility of epocrates.
Contenders(8)
Both platforms target clinical professionals and students in hospital environments, competing for screen time during high-pressure shifts via offline-accessible clinical reference tools.
Both applications target healthcare professionals with drug reference data, forcing a direct competition for clinical lookup time and utility.
Both platforms provide overlapping drug reference and pill identification tools, creating direct competition for clinical decision support and medication management among healthcare professionals and patients.
Both platforms target the same clinical audience of physicians and pharmacists, competing directly on drug interaction checking and offline reference utility.
Both apps target U.S. healthcare professionals for point-of-care clinical decision support, creating direct competition for daily clinical workflow time.
Both apps provide drug reference databases and dosing tools to healthcare professionals, directly competing for clinical utility during medication administration.
Both platforms target healthcare professionals with clinical decision support tools and offline access, creating direct competition for daily clinical workflow usage.
Both apps target U.S. healthcare professionals with clinical decision support tools, drug interaction checkers, and medical reference databases.
Same space(17)
Serves as a privacy-focused utility for users managing injectable peptide reconstitution, operating as a standalone tool.
Provides a specialized calculator for peptide dosage and reconstitution that addresses a specific niche not covered by general drug references.
Centralizes clinical communication and documentation, creating a high-frequency professional network that complements drug lookup utilities.
Focuses on knowledge retention through flashcard-based testing for medical and pharmacy students.
Integrates hardware-based diagnostic data into the physical exam workflow, providing a specialized diagnostic layer beyond drug information.
Delivers high-yield clinical cases for exam preparation, focusing on connecting drug mechanisms to patient scenarios.
Simulates clinical scenarios to build therapeutic reasoning skills for students, moving beyond static drug information.
Acts as a study aid for board examinations, focusing on educational content rather than clinical practice tools.
Provides a visual anatomical reference library that supports clinical education alongside drug-focused decision tools.
Offers evidence-based clinical decision rules that extend the utility of drug information into active patient risk assessment.
Automates medication inventory management through computer vision, serving as a specialized tool for pharmacy workflows.
Serves as a research-based search tool for general health information that complements clinical drug references.
Simplifies complex pharmacology concepts for students through curated notes and practice questions.
Provides emergency medicine knowledge that acts as a rapid-reference database for clinicians during high-pressure practice.
Delivers peer-reviewed medical search results that provide deeper clinical context than standard drug reference databases.
Facilitates administrative tasks like appointment booking and prescription ordering that fall outside the scope of clinical drug references.
Provides specialized infusion rate calculations for intravenous fluids, serving as a bedside tool for clinicians.
The Analyst's Read
The bottom line on Epocrates
Bottom line
Epocrates is a well-entrenched incumbent in the medical category, but its current trajectory shows a tension between revenue-focused monetization and the reliability required for clinical environments. Its market position is currently sustained by historical dominance rather than high user sentiment.
Frequently asked questions
How many apps does Epocrates publish?
What kind of apps does Epocrates make?
What is Epocrates's top app?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 1
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- yes